Table 2. Associations of female direct genetic variance with IGEs in male CHCs.
Experiment 2
|
Experiment 3
|
|||
---|---|---|---|---|
a1 | b1 | gmax | CovA | |
Z,Z-5,9-C25:2 | 0.575 | 0.575 | 0.382 | 0.053 |
Z-9-C25:1 | 0.417 | 0.417 | 0.287 | 0.038 |
Z-9-C26:1 | 0.317 | 0.317 | 0.301 | 0.086* |
2-Me-C26 | 0.124 | 0.127 | 0.063 | −0.072 |
Z,Z-5,9-C27:2 | 0.431 | 0.431 | 0.532 | 0.052 |
2-Me-C28 | 0.285 | 0.281 | 0.266 | −0.060 |
Z,Z-5,9-C29:2 | 0.204 | 0.204 | 0.464 | −0.112* |
2-Me-C30 | 0.266 | 0.270 | 0.329 | −0.090* |
Experiment 2: First principal vectors from a comparison of female CHC direct genetic variance (a1) and male CHC indirect genetic variance (b1), and the first principal component of GDEG (gmax). Experiment 3: Direct-indirect genetic covariance between female condition and male CHCs (CovA) for field-caught males (*, P<0.05).